Precision Medicine and Mysteries in Clinical Microbiology: Rationalizing Epidemiology, Genotype and Phenotype to Guide Therapeutics.
Whole genome sequencing (WGS) using MinIon characterized high-risk clones of Escherichia coli and Klebsiella harboring bla NDM-5, bla OXA-181 and bla CTX-M-15, as well as Pseudomonas aeruginosa harboring bla NDM , in a patient who received healthcare in India. Synergy testing demonstrated the activity of aztreonam and ceftazime-avibactam in combination. This case illustrates a 'precision medicine' approach where deeper understanding of the genotype, through WGS, and of the phenotype, through synergy testing, formed the basis for rational combination therapy.